Novartis
NVS
NVS
1,146 hedge funds and large institutions have $18.5B invested in Novartis in 2021 Q4 according to their latest regulatory filings, with 157 funds opening new positions, 327 increasing their positions, 473 reducing their positions, and 76 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.35% less ownership
Funds ownership: 9.03% → 8.68% (-0.35%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
31% less repeat investments, than reductions
Existing positions increased: 327 | Existing positions reduced: 473
Holders
1,146
Holding in Top 10
3
Calls
$688M
Puts
$278M
Top Buyers
| 1 | +$196M | |
| 2 | +$149M | |
| 3 | +$83.3M | |
| 4 |
Two Sigma Advisers
New York
|
+$64.2M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
+$58.2M |
Top Sellers
| 1 | -$628M | |
| 2 | -$178M | |
| 3 | -$118M | |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$86.8M |
| 5 |
Dodge & Cox
San Francisco,
California
|
-$84.4M |